Korro Bio (NASDAQ:KRRO) said on Friday that it received U.S. FDA's orphan drug designation for investigational medicine ...
This week is World Orphan Week, and with it one group says the global crisis facing orphaned and vulnerable children demands ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback